What they were paid
Syndax Pharmaceuticals Director Compensation Table · all 4 fiscal years held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $67,500 | $366,250 | $0 | $0 | $433,750 |
| FY2024 | $62,759 | $378,760 | — | — | $441,519 |
| FY2022 | $56,925 | $252,640 | — | — | $309,565 |
| FY2021 | $17,708 | $0 | $480,697 | — | $480,697 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Syndax Pharmaceuticals Inc DEF 14A filed April 30, 2026, accession 0001193125-26-197859, and prior-year filings. Open the filing on EDGAR.
How this page was built: the Syndax Pharmaceuticals Inc filed document, accession 0001193125-26-197859. Every figure is read from that document and cited to the page and table it appears in. Filed April 30, 2026.
Get the Syndax Pharmaceuticals Board Governance Report
$433,750 Martin H. Huber, M.D, FY2025 total director compensation
$500
The free page is the headline figures. The board report is director pay, board composition and committee fees combined into the same kind of document.
Data as of April 30, 2026 · Source: Velarion Executive Compensation Database, deposited on Zenodo (doi:10.5281/zenodo.22283855).
How this board is paid
company policy · FY2025Syndax Pharmaceuticals pays directors a $50,000 cash retainer and $366,250 in equity.
Committees
FY2025 · as the proxy prints themNominating/Governance · Science and Technology (Chair)
The rest of the Syndax Pharmaceuticals board
FY2025 · as the company reported each| Director | Role | FY2025 total |
|---|---|---|
| Aleksandra Rizo, M.D., Ph.D | Independent Director | $426,250 |
| Dennis G. Podlesak | Chair of the Board | $947,000 |
| Jennifer Jarrett | Independent Director | $433,750 |
| Keith A. Katkin | Independent Director | $511,250 |
| Michael A. Metzger | Director | — |
| Pierre Legault | Independent Director | $503,750 |
The full Syndax Pharmaceuticals compensation record
free company briefThis page is one director within Syndax Pharmaceuticals's record. The company brief lists every named executive and director, each linking to their own page.
Peer companies
named in the Syndax Pharmaceuticals proxy · each links to its own free briefOrder SNDX
Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.